Lupattelli et al. |
thalidomide |
10 to 40 |
Low health literacy: 84.5 |
Over-estimated |
|
|
|
Medium health literacy: 89.5 |
Over-estimated |
|
|
|
High health literacy: 94.8 |
Over-estimated |
Gils et al. |
thalidomide |
20 to 50 |
GP: 20 |
Properly-estimated |
|
|
|
OB/GYN: 20 |
Properly-estimated |
|
warfarin |
10 to 20 |
GP: 3 |
Under-estimated |
|
|
|
OB/GYN: 5 |
Under-estimated |
|
retinoids |
30 to 38 |
GP: 10 |
Under-estimated |
|
|
|
OB/GYN: 5 |
Under-estimated |
Nordeng et al. |
thalidomide |
10 to 40 |
All included women: 75 |
Over-estimated |
Damase-Michel et al. |
sodium valproate |
10 |
All healthcare
professionals: 41.8 |
Over-estimated |
|
lithium |
12 |
All healthcare professionals: 55.8 |
Over-estimated |
|
isotretinoin |
25 |
All healthcare professionals: 89 |
Over-estimated |
|
warfarin |
30 |
All healthcare professionals: 58.7 |
Over-estimated |
|
thalidomide |
50 |
All healthcare professionals: 91.7 |
Over-estimated |
Sanz et al. |
phenytoin |
≤ 10 |
Physicians: 37.9 |
Over-estimated |
|
|
|
Clinical students: 41.3 |
Over-estimated |
|
|
|
Pre-clinical students: 58.9 |
Over-estimated |
|
|
|
Non-pregnant women: 67.9 |
Over-estimated |
|
|
|
Pregnant women: 59.5 |
Over-estimated |
|
warfarin |
6 to 25 |
Physicians:53.2 |
Over-estimated |
|
|
|
Clinical students: 44.6 |
Over-estimated |
|
|
|
Pre-clinical students: 63.1 |
Over-estimated |
|
|
|
Non-pregnant women: 68.4 |
Over-estimated |
|
|
|
Pregnant women: 42.8 |
Over-estimated |
|
etretinate |
16 to 30 |
Physicians: 95.9 |
Over-estimated |
|
|
|
Clinical students: 55.1 |
Over-estimated |
|
|
|
Pre-clinical students: 59.7 |
Over-estimated |
|
|
|
Non-pregnant women: 45.8 |
Over-estimated |
|
|
|
Pregnant women: 16.4 |
Properly-estimated |
|
thalidomide |
11 to 35 |
Physicians: 81.6 |
Over-estimated |
|
|
|
Clinical students: 73.4 |
Over-estimated |
|
|
|
Pre-clinical students: 79.3 |
Over-estimated |
|
|
|
Non-pregnant women: 91.1 |
Over-estimated |
|
|
|
Pregnant women: 82.6 |
Over-estimated |
Pons et al. |
misoprostol |
>3 |
Non-pregnant women: 50 |
Properly-estimated |
|
|
|
Pregnant women: 50 |
Properly-estimated |
Petersen et al. |
thalidomide |
10 to 40 |
All included women: 94 |
Over-estimated |